BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 26996723)

  • 21. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
    Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
    Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults?
    Bahceci M; Gokalp D; Bahceci S; Tuzcu A; Atmaca S; Arikan S
    J Endocrinol Invest; 2007 Mar; 30(3):210-4. PubMed ID: 17505154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis.
    Liu C; Feng X; Li Q; Wang Y; Li Q; Hua M
    Cytokine; 2016 Oct; 86():100-109. PubMed ID: 27498215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of a School-Based Intervention Protocol - ACORDA Project - On Adipokines in An Overweight and Obese Pediatric Population.
    Nascimento H; Alves AI; Medeiros AF; Coimbra S; Catarino C; Bronze-da-Rocha E; Costa E; Rocha-Pereira P; Silva G; Aires L; Seabra A; Mota J; Ferreira Mansilha H; Rêgo C; Santos-Silva A; Belo L
    Pediatr Exerc Sci; 2016 Aug; 28(3):407-16. PubMed ID: 27176449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between ferritin and hepcidin levels and inflammatory status in patients with type 2 diabetes mellitus and obesity.
    Andrews M; Soto N; Arredondo-Olguín M
    Nutrition; 2015 Jan; 31(1):51-7. PubMed ID: 25441587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary glycemic index/load and peripheral adipokines and inflammatory markers in elderly subjects at high cardiovascular risk.
    Bulló M; Casas R; Portillo MP; Basora J; Estruch R; García-Arellano A; Lasa A; Juanola-Falgarona M; Arós F; Salas-Salvadó J
    Nutr Metab Cardiovasc Dis; 2013 May; 23(5):443-50. PubMed ID: 22209741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of biomarkers in type 2 diabetic subjects without any complications.
    Bhaktha G; Nayak S; Shantaram M
    Diabetes Metab Syndr; 2016; 10(1):1-3. PubMed ID: 26375580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RELATIONSHIP OF ADIPOKINES AND PROINFLAMMATORY CYTOKINES AMONG ASIAN INDIANS WITH OBESITY AND YOUTH ONSET TYPE 2 DIABETES.
    Gokulakrishnan K; Amutha A; Ranjani H; Bibin SY; Balakumar M; Pandey GK; Anjana RM; Ali MK; Narayan KM; Mohan V
    Endocr Pract; 2015 Oct; 21(10):1143-51. PubMed ID: 26151423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study.
    Mirza S; Hossain M; Mathews C; Martinez P; Pino P; Gay JL; Rentfro A; McCormick JB; Fisher-Hoch SP
    Cytokine; 2012 Jan; 57(1):136-42. PubMed ID: 22035595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Selected Adipocytokines and Inflammatory Markers on Body Mass Index in Type 2 Diabetes Patients in Saudi Arabia and as Risk Factors to Cardiovascular Disease.
    Anandaraj AA; Syed Ismail PM; Namis SM; Bajnaid YJ; Shetty SB; Almutairi KM
    Curr Diabetes Rev; 2017; 13(3):330-335. PubMed ID: 27296168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The adipokine Chemerin and Fetuin-A Serum Levels in Type 2 Diabetes Mellitus: Relation to Obesity and Inflammatory Markers.
    El-Deeb TS; Bakkar SM; Eltoony L; Zakhary MM; Kamel AA; Nafee AM; Hetta HF
    Egypt J Immunol; 2018 Jan; 25(1):191-202. PubMed ID: 30243011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of hepatokines with markers of endothelial dysfunction and vascular reactivity in obese adolescents.
    Stein D; Ovadia D; Katz S; Brar PC
    J Pediatr Endocrinol Metab; 2024 Apr; 37(4):309-316. PubMed ID: 38404032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adiponectin, leptin and high sensitivity C-reactive protein values in obese children - important markers for metabolic syndrome?
    Stroescu RF; Mărginean O; Bizerea T; Gafencu M; Voicu A; Doroș G
    J Pediatr Endocrinol Metab; 2019 Jan; 32(1):27-31. PubMed ID: 30530892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients.
    Jung CH; Kim BY; Kim CH; Kang SK; Jung SH; Mok JO
    Cardiovasc Diabetol; 2012 Mar; 11():24. PubMed ID: 22413919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective Relation of Circulating Adipokines to Incident Metabolic Syndrome: The Framingham Heart Study.
    Zachariah JP; Quiroz R; Nelson KP; Teng Z; Keaney JF; Sullivan LM; Vasan RS
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28713076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation between the inflammatory factors and adipocytokines with gestational diabetes mellitus and their change in puerperium].
    Liu T; Fang Z; Yang D; Liu Q
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):436-9. PubMed ID: 22932110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance.
    Monzillo LU; Hamdy O; Horton ES; Ledbury S; Mullooly C; Jarema C; Porter S; Ovalle K; Moussa A; Mantzoros CS
    Obes Res; 2003 Sep; 11(9):1048-54. PubMed ID: 12972674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of adiponectin and inflammatory cytokines on diabetic vascular complications in obese and non-obese patients with type 2 diabetes mellitus.
    Hong SB; Lee JJ; Kim SH; Suh YJ; Han JY; Kim YS; Nam M
    Diabetes Res Clin Pract; 2016 Jan; 111():58-65. PubMed ID: 26589367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetuin-A levels in lean and obese women with polycystic ovary syndrome.
    Kozakowski J; Jeske W; Zgliczyński W
    Endokrynol Pol; 2014; 65(5):371-6. PubMed ID: 25301487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.
    Mraz M; Bartlova M; Lacinova Z; Michalsky D; Kasalicky M; Haluzikova D; Matoulek M; Dostalova I; Humenanska V; Haluzik M
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):369-75. PubMed ID: 19702724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.